可溶性尿激酶型纤溶酶原激活物受体，一种循环性肾脏疾病因子。
suPAR, a Circulating Kidney Disease Factor.
作者信息
Wei Changli, Spear Ryan, Hahm Eunsil, Reiser Jochen
机构信息
Department of Medicine, Rush University Medical Center, Chicago, IL, United States.
出版信息
Front Med (Lausanne). 2021 Oct 6;8:745838. doi: 10.3389/fmed.2021.745838. eCollection 2021.
Urokinase plasminogen activator receptor (uPAR) is a multifaceted, GPI-anchored three-domain protein. Release of the receptor results in variable levels of soluble uPAR (suPAR) in the blood circulation. suPAR levels have been linked to many disease states. In this mini-review, we discuss suPAR as a key circulating molecule mediating kidney disease with a particular focus on differently spliced isoforms.
尿激酶型纤溶酶原激活物受体（uPAR）是一种多面的、糖基磷脂酰肌醇锚定的三结构域蛋白。该受体的释放导致血液循环中可溶性uPAR（suPAR）水平的变化。suPAR水平与多种疾病状态相关。在这篇小型综述中，我们将讨论suPAR作为介导肾脏疾病的关键循环分子，特别关注不同剪接异构体。
Zotero 插件